News & Events
Lucid Genomics at ASHG 2025 conference and industry session
2025 October 16
We were at ASHG 2025 with our booth and Professor Pawel Stankiewicz from Baylor College of Medicine lead our Industry Education Session showcasing how non-coding and structural variants reveal disease mechanisms, powered by Lucid’s AI platform
Lucid Genomics at BioTechX 2025 conference
2025 September 30
We participated in BioTechX Europe engaging with biotech and pharma leaders on how we can support the detection and interpretation of structural variants to accelerate biomarker discovery and patient stratification in drug discovery
The 100 most important minds in Berlin science 2025
2025 October 10
Our CEO Uirá Souto Melo and CTO M-Hossein Moeinzadeh have been recognized among Tagesspiegel’s “100 most important minds in Berlin science 2025.” The recognition highlights how Lucid Genomics is bringing the non-coding genome into mainstream awareness
Lucid Genomics sponsors GooD conference
2025 September 10
We sponsored and attended the Genetics of Ocular Development (GoOD) Meeting 2025 in Ghent, joining clinicians and scientists in ophthalmology to highlight how 3D genome analysis uncovers hidden disease-causing variants
Lucid Genomics on Drug Discovery panel
2025 July 10
CEO Uirá Souto Melo joined a panel discussion on how TechBio is accelerating drug discovery and development. Hosted by Future4care
Our latest whitepaper is out!
Here we explain DICAST, a novel machine learning model that detects SVs from short-read data.
Read the paper through the link!
2025 May 28
Lucid Genomics at the European Society of Human Genetics
The ESHG was a great time to finally see some familiar people in person and show our latest developments to new experts
2025 May 25
Episode 34 of the BioRevolution podcast
Hossein was a guest at the BioRevolution podcast to talk about the new insights into the genetic basis of diseases
2025 May 5
Product launch Lucid Genome Suite
2025 April 15
We hosted our first-ever product launch webinar, and it was an inspiring start
Funding by the European Regional Development Fund
Lucid Genomics is now funded by the European Regional Development Fund (EFRE) through the Investitionsbank Berlin (IBB)
2025 March 25
Lucid Genomics at the Future4Care Demo Day
2025 March 17
The Future4Care Demo Day was a great opportunity to discuss AI in healthcare and Lucid’s vision with a strong network of leading healthcare innovators
Achim Geppert as Co-Founder and Chief Commercial Officer
2025 March 3
As of February 1st, Achim Geppert joined Lucid Genomics as third Co-Founder and Chief Commercial Officer
Lucid Genomics at Festival of Genomics & Biodata 2025
2025 Jan. 31
During the FoG 2025 in London, we were able to connect with many experts and demo our software and solutions.
Bayer Co.Lab opening in Berlin
2024 Nov. 10
Lucid Genomics and other inspiring start-ups were invited to pitch at the Bayer Co.Lab opening in Berlin.
Visit of the French Minister of Higher Education
2024 Nov. 08
Welcoming French Minister of Higher Education and Research Patrick Hetzel to K.I.E.Z. Künstliche Intelligenz Entrepreneurship Zentrum.
Time to celebrate Lucid Genomics
2024 Oct. 31
We enjoyed celebrating our first event with everyone who supported our journey and discussed recent developments in our field
Lucid Genomics secures pre-seed funding
2024 Sept. 02
We raised €1.3 million in a pre-seed funding round led by Caesar Ventures and other supporters
Interview by K.I.E.Z.
2024, Aug. 25
The K.I.E.Z. program was a big contributor to our journey, with whom we developed this pitch
Interview by Berlin Partner
2024, June. 12
Read our interview with Berlin Partner about the early stages of setting up a start-up in Berlin.
Interview by Start2 Group
2022 Mar. 01
Listen to our interview with Start2 Group, in which we explain how Lucid Genomics is leveraging AI to extract 100% of the information from DNA datasets.
Stay informed
Stay informed with the latest updates, news, and insights delivered to your inbox.